GPs to take lead role in COVID-19 vaccine rollout
Thursday, 14 January, 2021
The (RACGP) has welcomed government confirmation that GPs will be at the forefront of Australia鈥檚 COVID-19 vaccine rollout.
鈥淭his is a massive undertaking for our country and GPs will be essential,鈥 RACGP President Dr Karen Price said.
鈥淭he majority of Australians go to their GP for their vaccinations and for many Australians they will do the same for their COVID-19 vaccine.
鈥淰accinations are one of the greatest success stories of modern medicine and GP-led vaccination programs have been at the forefront all along.鈥
Dr Price said the RACGP is working with government on the rollout, which was brought forward to mid-to-late February, with high-priority groups to receive the vaccine first.
鈥淲e are having constructive discussions with the Minister for Health and the Health Department on the COVID-19 vaccine rollout to help make sure Australia gets it right.
鈥淕eneral practice is well positioned to support the rollout 鈥 there are GPs living and working in communities right across our country, in cities, rural towns and remote Aboriginal and Torres Strait Islander communities.
鈥淲e are talking to government to ensure GPs are appropriately supported to help with this mass vaccine drive and ensure vaccines are delivered safely and effectively across Australia.鈥
Dr Price iterated the importance of achieving high immunisation rates to protect Australians from the COVID-19 virus.
鈥淭here are many challenges ahead, including the need to build community confidence in the new vaccines through evidence-based information campaigns that address the community鈥檚 specific concerns and deal with misinformation and myths,鈥 she said.
鈥淭hese challenges also underpin why general practice will be so crucial in the rollout. GPs are perfectly placed to increase vaccine confidence and uptake. We are connected to our communities, we know our patients and they trust us.
鈥淭his is especially true for GPs who engage with culturally and linguistically diverse communities and Aboriginal and Torres Strait Islander peoples. The GPs who live and work in these communities will know how to talk to their patients in a culturally appropriate way, and discuss any concerns patients may have.鈥
The RACGP President also commented that general practice is one of the safest places for patients to receive their COVID-19 vaccine.
鈥淕Ps draw on a patient history and are equipped with the necessary medical training and facilities to manage any rare adverse reactions. General practice is also connected to the Australian Immunisation Register, which will ensure accurate record keeping of vaccine uptake.鈥
Dr Price said the fact that GPs are a priority group to receive the vaccine reflects the critical role GPs have and continue to play in responding to COVID-19.
鈥淕Ps are a priority group to receive the vaccine 鈥 the majority will receive the vaccine in phase 1b, with those working in GP-led respiratory clinics set to receive it in phase 1a of the rollout. This is important for the protection of GPs on the frontline working in respiratory clinics, and those caring for communities across the country.
鈥淭he vaccine rollout is a complicated and logistically challenging task. Thankfully Australia is in a good place to get the job done, and do it well, as we have very low rates of the virus in Australia compared to other countries, and we have a world-class general practice system that鈥檚 perfectly positioned to help.
鈥淭he RACGP looks forward to working with the Commonwealth and states and territories in supporting the vaccine rollout.鈥
The RACGP is providing on the vaccine to support GPs and patients.
Victoria's Q3 median ED wait times the lowest on record
Victoria's quarter three performance data (January–March) has shown improvement across...
Irregularities in a clinician's cases prompt 15-month lookback
St Vincent's 黑料吃瓜群网 Sydney has detailed a 15-month lookback review — prompted by...
Two researchers receive $899,000 in cardiovascular funding
In heart-related news this Heart Week (5–11 May), two University of Newcastle researchers...